Tokyo, Oct. 31 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000048282) titled 'Intervention study of the effect of collagen peptide intake on motor function' on Oct. 31.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Josai University
Condition:
Condition - Frail
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In Japan, which has entered an aging society, it is said that long-term care prevention = frailty prevention = locomotive prevention, and attention is being paid to maintaining and improving the quantity and quality of exercise equipment, especially muscles. It is also important for athletes to maintain and improve muscle mass and quality. We planned a study that oral intake of collagen affects the maintenance and improvement of muscle mass and quality, and maintains and improves motor function. There are already reports of human studies showing that oral collagen intake improves motor function under some limited conditions. There are also reports on the mechanism of action of collagen peptide on muscle cells at the cellular level. From these facts, there is sufficient legitimacy for the science and safety of this study. On the other hand, since the human test for locomotorium lasts for a long period of several months, by adding vitamins to the placebo group and having them take both dietary education and exercise programs, they became a placebo group. Reduce the disadvantages of this.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - 3 months, collagen peptide 10g / day with vitamin C,
vitamin E, every day
Interventions/Control_2 - 3 months, placebo(vitamin C, vitamin E), every day
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - Students, faculty and staff belonging to Josai University and residents of Tokigawa Town
Key exclusion criteria - (1) Those who have food allergies (gelatin)
(2) Those who use a cardiac pacemaker
(3) Persons with kidney disease
(4) Persons who need assistance in exercising or eating
Target Size - 45
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2022 Year 01 Month 31 Day
Anticipated trial start date - 2022 Year 08 Month 01 Day
Last follow-up date - 2023 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054861
Disclaimer: Curated by HT Syndication.
